Last scanned
Domain Age
Daily Visitors
Global Rank
Updated:
Adalimumab India - Adalimumab Dosage - Adalimumab - Adalimumab Biosimilar - Biosimilar Of Adalimumab
Adalimumab, trade name Exemptia, is a potent TNF-inhibitor and anti-inflammatory drug manufactured and promoted by Zydus Cadila in India. Adalimumab Biosimilar Dosage is prescribed to people who have Psoriatic and Rheumatoid Arthritis.
This website is hosted with GoDaddy.com, LLC, which reserves the following IP addresses for exemptia.com: 104.238.72.103. Moreover, DNS used with this website include ns35.domaincontrol.com, ns36.domaincontrol.com. Subnet identifier ranges from 104.238.64.0 to 104.238.127.255. Classless Inter-Domain Routing (CIDR) is 104.238.64.0/18. ARIN net type is Direct Allocation.
Last scanned
Domain Age
Daily Visitors
Global Rank
ns35.domaincontrol.com
ns36.domaincontrol.com
{{value}}
2014-10-18
2024-10-18
PDR LTD. D/B/A PUBLICDOMAINREGISTRY.COM
{{value}}
The registrar of exemptia.com is PDR LTD. D/B/A PUBLICDOMAINREGISTRY.COM and the name expires on 2024-10-18. According to open source data, you can reach the owner at daemonindia@gmail.com but please make sure you have a good reason for unsolicited messages. Their country of residence is India.
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
655.9K
N/A
444.2K
534